ACTRN12612000968875招募中未知
In adults with non-progressive dysarthria resulting from stroke or traumatic brain injury, does CLEAR SPEECH compared to traditional speech therapy techniques result in greater improvements in speech intelligibility
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •To be eligible to participate in the study, participants will be required to be English speaking, have mild to severe non-progressive dysarthria as diagnosed by a speech pathologist, be 6 months post neurological incident, and have a cognitive status that is adequate to participate in assessment tasks. Prior to commencing the study participants will also undergo stimulability testing to assess whether they have the potential for improvements in speech clarity. Only potential participants who are able to demonstrate improvements for speech clarity will be included in the study.
排除标准
- •Potential participants will be excluded if, in addition to their dysarthria, they present with a co-morbid condition that may negatively impact on their ability to complete speech therapy. Such conditions include significant aphasia, hearing or vision loss, dementia, apraxia of speech, or post traumatic amnesia. Prior to inclusion in the study research personnel will screen all potential participants.
研究者
相似试验
招募中
不适用
Clinical study on the treatment of dysarthria after stroke by Kaiyin xuanfei manipulation.Dysarthria after strokeITMCTR2100005204The First Affiliated Hospital of Henan University of Chinese Medicine
已完成
不适用
Clinical studies for improvements dysarthria using pitch and loudness training software (Smart speech program) in patients with dysarthriaKCT0004955Chonbuk National University Hospital20
已完成
不适用
Speech treatment in Autosomal recessive spastic ataxia of Charlevoix-SaguenayDysarthriaAutosomal recessive spastic ataxia of Charlevoix-SaguenayAtaxiaHuman Genetics and Inherited Disorders - Other human genetics and inherited disordersNeurological - Neurodegenerative diseasesPhysical Medicine / Rehabilitation - Speech therapyACTRN12616001583437The University of Melbourne10
招募中
不适用
Speech treatment for spinocerebellar ataxia and Friedreich ataxiaNeurological - Neurodegenerative diseasesPhysical Medicine / Rehabilitation - Speech therapyDysarthriaFriedreich ataxiaSpinocerebellar ataxiaACTRN12616001582448The University of Melbourne30
已完成
2 期
A Phase II study in adult patients with newly-diagnosed chronic myeloid leukaemia of initial intensified Glivec® therapy, and sequential combination therapy for non-responders. With Protocol Amendments October 2004: to include an Extension Phase of the StudyACTRN12607000614493Australasian Leukaemia and Lymphoma Group103